Content about Pharmaceutical industry

March 8, 2010
GPhA hopes Office of Generic Drugs gets more funding from Congress

An organization representing the generic drug industry is hoping that Congress gives the Food and...

March 8, 2010
Teva names Frost new chairman of the board

The world’s largest maker of generic drugs has appointed a new chairman....

March 8, 2010
Watson seeks approval for generic Opana

Watson Pharmaceuticals has filed a regulatory approval application for a generic version of a painkiller...

March 7, 2010
Taro receives FDA approval for skin cancer generic

The Food and Drug Administration has approved Taro Pharmaceutical Industries’ generic version of a drug...

March 4, 2010
Acorda announces availability of MS treatment

A new drug by Acorda Therapeutics for treating multiple sclerosis has become available, Acorda announced....

March 4, 2010
CVS partnership may drive down healthcare costs

CVS Caremark’s Behavior Change Research Partnership with several leading universities is likely to yield some...

WHAT IT MEANS AND WHY IT'S IMPORTANT CVS Caremark’s Behavior Change Research Partnership with several leading universities is likely to yield some invaluable results for the industry at large because if CVS Caremark executives and the participating academic leaders can better understand customer behavior and develop ways to encourage improved healthy behaviors, then the end result likely will be lower healthcare costs.

March 4, 2010
Mylan gets upgrade from Moody's

Generic drug maker Mylan got an upgrade in its credit rating from Moody’s Investors Service,...

March 4, 2010
OrbiMed Advisors: Astellas should raise bid for OSI

One of the biggest holders of OSI Pharmaceuticals’ stock has said Japanese drug maker Astellas...

March 4, 2010
Report: Office of Generic Drugs head steps down

The head of the Food and Drug Administration’s generic drug division is stepping down to...

March 3, 2010
Bristol-Myers Squibb discusses pipeline with investors

Aims of becoming a leader in biotechnology headlined a meeting Thursday between Bristol-Myers Squibb and...

March 2, 2010
FDA issues complete response letter to Bristol-Myers Squibb

The Food and Drug Administration has declined to approve a biotech drug for organ transplant...

March 2, 2010
GPhA: GAO report highlights need for availability of biogenerics

An organization representing the generic drug industry is holding up a recent report by the...

March 2, 2010
Norditropin FlexPro receives FDA approval

The Food and Drug Administration has approved a Novo Nordisk treatment for growth hormone disorders,...

March 2, 2010
Pfizer may buy Ratiopharm

It appears that Pfizer has changed its mind a second time about buying Ratiopharm....

March 1, 2010
Court: Teva to receive market exclusivity for generic Hyzaar, Cozaar

The U.S. Court of Appeals for the District of Columbia has overturned a district court...

March 1, 2010
FDA approves extended-release painkiller

The Food and Drug Administration has approved a regulatory approval application for a pain drug...

March 1, 2010
Impax Labs receives FDA approval for generic tamsulosin

The Food and Drug Administration has approved the first generic version of a drug for...

February 28, 2010
Astellas vies for OSI Pharmaceuticals

A Japanese drug maker hopes to buy up a pharmaceutical company based in New York...

February 28, 2010
AstraZeneca to buy drugs it developed with Merck

AstraZeneca plans to buy Merck & Co.’s interest in several drug products that the two...

February 28, 2010
FDA accepts regulatory application for Qnexa

The Food and Drug Administration has accepted a regulatory approval application for a drug to...

February 28, 2010
FDA, EMEA adopt orphan drug report system

Companies developing drugs to treat especially rare conditions may find winning regulatory approval in the...

February 28, 2010
Merck's R&D pipeline gets a boost

Merck & Co.’s acquisition of Schering-Plough has delivered a big boost to the drug maker’s...

February 28, 2010
Reporters Notebook

GlaxoSmithKline has identified more than 5,500 rare diseases it potentially could target as part of...

February 28, 2010
The biggest Little Pharma in the world

With exception to those companies that are the first to win Food and Drug Administration...

February 25, 2010
Fougera receives FDA approval for generic Aldara

The Food and Drug Administration has given E. Fougera & Co. approval for the first...